Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary disease.

Huiberts A, Zweijpfenning SMH, Pennings LJ, Boeree MJ, van Ingen J, Magis-Escurra C, Hoefsloot W.

Eur Respir J. 2019 Jul 11;54(1). pii: 1802143. doi: 10.1183/13993003.02143-2018. Print 2019 Jul. No abstract available.

PMID:
31000680
2.

Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary Mycobacterium avium complex disease.

Zweijpfenning SMH, Schildkraut JA, Coolen JPM, Ruesen C, Koenraad E, Janssen A, Ruth MM, de Jong AS, Kuipers S, Aarnoutse RE, Magis-Escurra C, Hoefsloot W, van Ingen J.

Eur Respir J. 2019 Jul 11;54(1). pii: 1900118. doi: 10.1183/13993003.00118-2019. Print 2019 Jul. No abstract available.

PMID:
31000671
3.

Nontuberculous mycobacterial pulmonary disease and Aspergillus co-infection: Bonnie and Clyde?

Geurts K, Zweijpfenning SMH, Pennings LJ, Schildkraut JA, Boeree MJ, Magis-Escurra C, van der Lee H, Verweij PE, Hoefsloot W, van Ingen J.

Eur Respir J. 2019 Jul 4;54(1). pii: 1900117. doi: 10.1183/13993003.00117-2019. Print 2019 Jul. No abstract available.

PMID:
30956203
4.

M ycobacterium abscessus pulmonary disease: individual patient data meta-analysis.

Kwak N, Dalcolmo MP, Daley CL, Eather G, Gayoso R, Hasegawa N, Jhun BW, Koh WJ, Namkoong H, Park J, Thomson R, van Ingen J, Zweijpfenning SMH, Yim JJ.

Eur Respir J. 2019 Jul 11;54(1). pii: 1801991. doi: 10.1183/13993003.01991-2018. Print 2019 Jul.

PMID:
30880280
5.

A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.

Ruth MM, Sangen JJN, Remmers K, Pennings LJ, Svensson E, Aarnoutse RE, Zweijpfenning SMH, Hoefsloot W, Kuipers S, Magis-Escurra C, Wertheim HFL, van Ingen J.

J Antimicrob Chemother. 2019 Apr 1;74(4):935-943. doi: 10.1093/jac/dky526.

PMID:
30649327
6.

Clofazimine does not lead to significant QT interval prolongation: a multicentre study.

Zweijpfenning SMH, van Groningen H, van Ingen J, Magis-Escurra C, Boeree MJ, Wagner D, Bax H, Andrejak C, Wener R, Rahman A, Kunst H, Lorent N, Brouwer MA, Hoefsloot W; NTM-NET.

Eur Respir J. 2018 Nov 1;52(5). pii: 1801386. doi: 10.1183/13993003.01386-2018. Print 2018 Nov. No abstract available.

PMID:
30385602
7.

Dissemination of localized Mycobacterium malmoense infection in an immunocompromised patient.

Zweijpfenning SMH, Schipper L, Duurkens VAM, Harbers JB, van Ingen J, Hoefsloot W.

Int J Infect Dis. 2018 Nov;76:35-37. doi: 10.1016/j.ijid.2018.08.019. Epub 2018 Sep 7.

8.

Geographic Distribution of Nontuberculous Mycobacteria Isolated from Clinical Specimens: A Systematic Review.

Zweijpfenning SMH, Ingen JV, Hoefsloot W.

Semin Respir Crit Care Med. 2018 Jun;39(3):336-342. doi: 10.1055/s-0038-1660864. Epub 2018 Aug 2.

PMID:
30071548

Supplemental Content

Loading ...
Support Center